-
First Global DPP1 Inhibitor Approved by FDA
FDA
The FDA has approved brensocatib, the world’s first DPP1 inhibitor, for treating non-cystic fibrosis bronchiectasis in patients aged 12+, marking a breakthrough in targeted respiratory therapies.
-
沂源县|
信阳市|
怀柔区|
家居|
白水县|
榕江县|
祁东县|
莆田市|
晋中市|
平塘县|
荆州市|
南昌市|
黔西|
县级市|
兖州市|
卓资县|
定边县|
兰考县|
道真|
随州市|
平山县|
新野县|
甘孜|
咸丰县|
东丽区|
河南省|
镇原县|
定远县|
遂宁市|
鲜城|
全南县|
延长县|
阜城县|
余干县|
弥渡县|
博野县|
仙居县|
恩施市|
龙里县|
澎湖县|
固阳县|